BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 3281561)

  • 1. Current status of radioligand antibodies in the treatment of malignancy.
    Maners AW; Sanders MM; Pappas AA
    Ann Clin Lab Sci; 1988; 18(1):53-7. PubMed ID: 3281561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal hybridoma antibodies in human melanoma: current status.
    Burk MW
    Int Adv Surg Oncol; 1984; 7():241-70. PubMed ID: 6205999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fractionated radioimmunotherapy of human colon carcinoma xenografts with 131I-labeled monoclonal antibody CC49.
    Buchsbaum D; Khazaeli MB; Liu T; Bright S; Richardson K; Jones M; Meredith R
    Cancer Res; 1995 Dec; 55(23 Suppl):5881s-5887s. PubMed ID: 7493364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal antibodies against human solid tumors.
    Burtin P; Nardelli J
    Bull Cancer; 1983; 70(2):108-12. PubMed ID: 6191805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies.
    Bodey B; Siegel SE; Kaiser HE
    Anticancer Res; 1996; 16(2):661-74. PubMed ID: 8687112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production of anti-tumor human monoclonal antibodies using different approaches.
    Liu H; Xu ZL; Wang Y; Yang L; Feng O; Li Y; Wang YM; Zhang GG
    Hum Antibodies Hybridomas; 1993 Jan; 4(1):2-8. PubMed ID: 8381684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor immunotherapy in the mouse with the use of 131I-labeled monoclonal antibodies.
    Zalcberg JR; Thompson CH; Lichtenstein M; McKenzie IF
    J Natl Cancer Inst; 1984 Mar; 72(3):697-704. PubMed ID: 6583453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human monoclonal IgM antibodies with apoptotic activity isolated from cancer patients.
    Brändlein S; Lorenz J; Ruoff N; Hensel F; Beyer I; Müller J; Neukam K; Illert B; Eck M; Müller-Hermelink HK; Vollmers HP
    Hum Antibodies; 2002; 11(4):107-19. PubMed ID: 12775891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody-guided irradiation of malignant ascites in ovarian cancer: a new therapeutic method possessing specificity against cancer cells.
    Epenetos AA; Hooker G; Krausz T; Snook D; Bodmer WF; Taylor-Papadimitriou J
    Obstet Gynecol; 1986 Sep; 68(3 Suppl):71S-74S. PubMed ID: 3737085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cloning of anti-breast cancer monoclonal antibodies from phage antibody libraries].
    Zhang G; Wang Y; Wang Y
    Zhonghua Zhong Liu Za Zhi; 1995 Jul; 17(4):258-62. PubMed ID: 7587890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of monoclonal antibodies to tumor diagnosis and therapy.
    Rosen ST; Winter JN; Epstein AL
    Ann Clin Lab Sci; 1983; 13(3):173-84. PubMed ID: 6347022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Monoclonal antibodies against human brain tumors].
    Yoshida J
    Gan To Kagaku Ryoho; 1983 Jul; 10(7):1706-14. PubMed ID: 6347088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental therapy of human breast tumors with 131I-labeled monoclonal antibodies prepared against the human milk fat globule.
    Ceriani RL; Blank EW
    Cancer Res; 1988 Aug; 48(16):4664-72. PubMed ID: 3396015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological and clinical implications of lymphocyte hybridomas: tumor therapy with monoclonal antibodies.
    Levy R; Miller RA
    Annu Rev Med; 1983; 34():107-16. PubMed ID: 6344750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic applications of monoclonal antibodies to human cancer.
    Borowitz MJ; Stein RB
    Arch Pathol Lab Med; 1984 Feb; 108(2):101-5. PubMed ID: 6546490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polyclonal and monoclonal antibodies as reagents in biochemical and in clinical-chemical analysis.
    Falkenberg FW; Pierard D; Mai U; Kantwerk G
    J Clin Chem Clin Biochem; 1984 Dec; 22(12):867-82. PubMed ID: 6527103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Derlin-1 is overexpressed on the tumor cell surface and enables antibody-mediated tumor targeting therapy.
    Ran Y; Hu H; Hu D; Zhou Z; Sun Y; Yu L; Sun L; Pan J; Liu J; Liu T; Yang Z
    Clin Cancer Res; 2008 Oct; 14(20):6538-45. PubMed ID: 18927294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nature's best weapons to fight cancer. Revival of human monoclonal IgM antibodies.
    Vollmers HP; Brändlein S
    Hum Antibodies; 2002; 11(4):131-42. PubMed ID: 12775893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of multiple bolus and continuous injections of 131I-labeled CC49 for therapy in a colon cancer xenograft model.
    Buchsbaum DJ; Khazaeli MB; Mayo MS; Roberson PL
    Clin Cancer Res; 1999 Oct; 5(10 Suppl):3153s-3159s. PubMed ID: 10541357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative metabolism and retention of iodine-125, yttrium-90, and indium-111 radioimmunoconjugates by cancer cells.
    Press OW; Shan D; Howell-Clark J; Eary J; Appelbaum FR; Matthews D; King DJ; Haines AM; Hamann P; Hinman L; Shochat D; Bernstein ID
    Cancer Res; 1996 May; 56(9):2123-9. PubMed ID: 8616860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.